POS1368 GENDER AS A KEY FACTOR OF DELAY IN PRESCRIBING THE FIRST BIOLOGIC OR TARGETED SYNTHETIC DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS. DATA FROM BIOBADASER 3.0 REGISTRY | Publicación